AKT-IN-27

MedChem Express

AKT-IN-27

5

Research Use Only

C21H15NO4S

377.41

AKT-IN-27 (4a) is a potential anticancer agent through selective therapeutic targeting of Akt-driven pathways. AKT-IN-27 (4a) induces apoptosis via caspase-3 activation, G2/M cell cycle arrest, and mitochondrial membrane potential disruption. AKT-IN-27 (4a) can be used in the research for TNBC (triple-negative breast cancer)[1].

O=C(C1=C(NC2=CC=CC=C2)SC(C3=O)=C1C(C4=C3C=CC=C4)=O)OCC

12352200